id stringlengths 11 11 | tags stringlengths 10 777 | text stringlengths 2 1.5k | dataset_num int64 1 3 | tokens list | ner_tags list |
|---|---|---|---|---|---|
NCT02419560 | 13:35:chronic_disease | Subject has malabsorption syndrome or other condition which may affect an enteral route of administration | 2 | [
"Subject",
"has",
"malabsorption",
"syndrome",
"or",
"other",
"condition",
"which",
"may",
"affect",
"an",
"enteral",
"route",
"of",
"administration"
] | [
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02316574 | 44:51:chronic_disease | History of severe alcohol withdrawal (e.g. seizure, delirium tremens, multiple detoxifications or ER visits for alcohol withdrawal) | 2 | [
"History",
"of",
"severe",
"alcohol",
"withdrawal",
"(",
"e.g",
".",
"seizure",
",",
"delirium",
"tremens",
",",
"multiple",
"detoxifications",
"or",
"ER",
"visits",
"for",
"alcohol",
"withdrawal",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01730937 | ,14:32:cancer,36:61:cancer,,188:229:treatment,233:265:treatment,284:293:chronic_disease,297:321:chronic_disease | At least one solid liver lesion or vascular tumor thrombosis (involving portal vein, inferior vena cava [IVC] and/or hepatic vein) > 1 cm with arterial enhancement and delayed washout on multi-phasic computerized tomography (CT) or magnetic resonance imaging (MRI) in the setting of cirrhosis or chronic hepatitis B or C... | 2 | [
"At",
"least",
"one",
"solid",
"liver",
"lesion",
"or",
"vascular",
"tumor",
"thrombosis",
"(",
"involving",
"portal",
"vein",
",",
"inferior",
"vena",
"cava",
"[",
"IVC",
"]",
"and/or",
"hepatic",
"vein",
")",
">",
"1",
"cm",
"with",
"arterial",
"enhancem... | [
0,
0,
0,
3,
3,
3,
0,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
2,
0,
2,
2,
2,
2,
2,
0,
0
] |
NCT02737930 | 12:28:chronic_disease | History of seizure disorder | 2 | [
"History",
"of",
"seizure",
"disorder"
] | [
0,
0,
2,
2
] |
NCT01389024 | ,47:63:chronic_disease | Participants whose MRI show a silent or overt cerebral infarct | 2 | [
"Participants",
"whose",
"MRI",
"show",
"a",
"silent",
"or",
"overt",
"cerebral",
"infarct"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT01434316 | 33:61:cancer,57:60:cancer,63:68:cancer,70:100:cancer,96:99:cancer | Subjects with treatment-related acute myeloid leukemia (AML) (t-AML)/myelodysplastic syndrome (MDS) or with features suggestive of AML/MDS | 2 | [
"Subjects",
"with",
"treatment-related",
"acute",
"myeloid",
"leukemia",
"(",
"AML",
")",
"(",
"t-AML",
")",
"/myelodysplastic",
"syndrome",
"(",
"MDS",
")",
"or",
"with",
"features",
"suggestive",
"of",
"AML/MDS"
] | [
0,
0,
0,
3,
3,
3,
3,
3,
0,
0,
3,
0,
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0
] |
NCT02513797 | 23:40:chronic_disease,42:65:chronic_disease,73:90:chronic_disease,100:140:treatment, | Documented history of cardiogenic shock, hemodynamic instability or any medical condition in which intra-aortic balloon pump (IABP) therapy is clinically indicated within 3 months prior to the planned study intervention | 2 | [
"Documented",
"history",
"of",
"cardiogenic",
"shock",
",",
"hemodynamic",
"instability",
"or",
"any",
"medical",
"condition",
"in",
"which",
"intra-aortic",
"balloon",
"pump",
"(",
"IABP",
")",
"therapy",
"is",
"clinically",
"indicated",
"within",
"3",
"months",
... | [
0,
0,
0,
2,
2,
0,
2,
2,
0,
0,
2,
2,
0,
0,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01238120 | 29:35:cancer | Have a primary diagnosis of cancer | 2 | [
"Have",
"a",
"primary",
"diagnosis",
"of",
"cancer"
] | [
0,
0,
0,
0,
0,
3
] |
NCT00716066 | 1:34:chronic_disease | Lambert-Eaton myasthenic syndrome | 2 | [
"Lambert-Eaton",
"myasthenic",
"syndrome"
] | [
2,
2,
2
] |
NCT02969187 | 10:33:treatment | Previous major abdominal surgery (possible adhesions and longer operation) | 2 | [
"Previous",
"major",
"abdominal",
"surgery",
"(",
"possible",
"adhesions",
"and",
"longer",
"operation",
")"
] | [
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT02759575 | 1:60:treatment | Prior radiation therapy to the larynx area or involved neck | 2 | [
"Prior",
"radiation",
"therapy",
"to",
"the",
"larynx",
"area",
"or",
"involved",
"neck"
] | [
1,
1,
1,
1,
1,
1,
1,
1,
1,
1
] |
NCT01804465 | 7:24:treatment,142:151:treatment,153:160:treatment | If no prior orchiectomy has been performed, patients must remain on luteinizing hormone-releasing hormone (LHRH) agonist or antagonist (e.g. degarelix) therapy | 2 | [
"If",
"no",
"prior",
"orchiectomy",
"has",
"been",
"performed",
",",
"patients",
"must",
"remain",
"on",
"luteinizing",
"hormone-releasing",
"hormone",
"(",
"LHRH",
")",
"agonist",
"or",
"antagonist",
"(",
"e.g",
".",
"degarelix",
")",
"therapy"
] | [
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1
] |
NCT02981173 | 8:26:chronic_disease,33:46:chronic_disease,48:57:chronic_disease,59:84:chronic_disease | Axis I psychotic disorder (e.g. schizophrenia, bipolar I, depression with psychosis) | 2 | [
"Axis",
"I",
"psychotic",
"disorder",
"(",
"e.g",
".",
"schizophrenia",
",",
"bipolar",
"I",
",",
"depression",
"with",
"psychosis",
")"
] | [
0,
0,
2,
2,
0,
0,
0,
2,
0,
2,
2,
0,
2,
2,
2,
0
] |
NCT02236377 | 8:30:chronic_disease | recent parasuicidal behaviors | 2 | [
"recent",
"parasuicidal",
"behaviors"
] | [
0,
2,
2
] |
NCT01861106 | ,68:71:chronic_disease,, | Clinical history of at least one life-threatening infection and/or MDS with International Prognostic Scoring System (IPSS) category of Intermediate-1, Intermediate-2 or High | 2 | [
"Clinical",
"history",
"of",
"at",
"least",
"one",
"life-threatening",
"infection",
"and/or",
"MDS",
"with",
"International",
"Prognostic",
"Scoring",
"System",
"(",
"IPSS",
")",
"category",
"of",
"Intermediate-1",
",",
"Intermediate-2",
"or",
"High"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02776761 | 27:53:chronic_disease | Any confirmed evidence of hepatitis B or C infection | 2 | [
"Any",
"confirmed",
"evidence",
"of",
"hepatitis",
"B",
"or",
"C",
"infection"
] | [
0,
0,
0,
0,
2,
2,
2,
2,
2
] |
NCT01966367 | 63:81:chronic_disease | The following additional exclusion criteria for patients with sickle cell anemia the following exclusion criteria also apply | 2 | [
"The",
"following",
"additional",
"exclusion",
"criteria",
"for",
"patients",
"with",
"sickle",
"cell",
"anemia",
"the",
"following",
"exclusion",
"criteria",
"also",
"apply"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT01992861 | 36:53:treatment,70:98:treatment,103:118:cancer | Patients who will undergo standard radiation therapy with concurrent cisplatin-based chemotherapy for cervical cancer | 2 | [
"Patients",
"who",
"will",
"undergo",
"standard",
"radiation",
"therapy",
"with",
"concurrent",
"cisplatin-based",
"chemotherapy",
"for",
"cervical",
"cancer"
] | [
0,
0,
0,
0,
0,
1,
1,
0,
0,
1,
1,
0,
3,
3
] |
NCT02400463 | 1:14:chronic_disease | Malabsorption | 2 | [
"Malabsorption"
] | [
2
] |
NCT02667418 | ,86:97:chronic_disease, | Current episode represents the first recurrent episode of CDI within 3 months of the primary CDI episode in a patient who has not had CDI in the 3 months prior to the primary episode | 2 | [
"Current",
"episode",
"represents",
"the",
"first",
"recurrent",
"episode",
"of",
"CDI",
"within",
"3",
"months",
"of",
"the",
"primary",
"CDI",
"episode",
"in",
"a",
"patient",
"who",
"has",
"not",
"had",
"CDI",
"in",
"the",
"3",
"months",
"prior",
"to",
... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01880567 | 21:24:cancer,35:72:treatment,74:82:treatment,84:95:treatment,97:134:treatment | Relapsed/refractory MCL: Requires treatment with strong cytochrome P450, family 3, subfamily A, polypeptide 4/5 (CYP3A4/5) inhibitors | 2 | [
"Relapsed/refractory",
"MCL",
":",
"Requires",
"treatment",
"with",
"strong",
"cytochrome",
"P450",
",",
"family",
"3",
",",
"subfamily",
"A",
",",
"polypeptide",
"4/5",
"(",
"CYP3A4/5",
")",
"inhibitors"
] | [
0,
3,
0,
0,
1,
1,
1,
1,
1,
0,
1,
1,
0,
1,
1,
0,
1,
1,
1,
1,
0,
0
] |
NCT02225548 | 21:38:chronic_disease | Subject with active peptic ulceration | 2 | [
"Subject",
"with",
"active",
"peptic",
"ulceration"
] | [
0,
0,
0,
2,
2
] |
NCT02542657 | 1:14:chronic_disease,,,70:77:cancer,112:126:treatment | Hypercalcemia (corrected serum calcium > 11.5 mg/dL) attributable to myeloma (e.g. not due to omitted doses of bisphosphonate) | 2 | [
"Hypercalcemia",
"(",
"corrected",
"serum",
"calcium",
">",
"11.5",
"mg/dL",
")",
"attributable",
"to",
"myeloma",
"(",
"e.g",
".",
"not",
"due",
"to",
"omitted",
"doses",
"of",
"bisphosphonate",
")"
] | [
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT02905370 | 1:48:chronic_disease | Deep vein thrombosis/pulmonary embolus (DVT/PE) | 2 | [
"Deep",
"vein",
"thrombosis/pulmonary",
"embolus",
"(",
"DVT/PE",
")"
] | [
2,
2,
2,
2,
2,
0,
0
] |
NCT02871726 | 26:43:treatment | Scheduled for an initial diagnostic biopsy | 2 | [
"Scheduled",
"for",
"an",
"initial",
"diagnostic",
"biopsy"
] | [
0,
0,
0,
0,
1,
1
] |
NCT02122172 | 19:35:treatment | Inability to take oral medications | 2 | [
"Inability",
"to",
"take",
"oral",
"medications"
] | [
0,
0,
0,
1,
1
] |
NCT02219711 | 1:19:treatment | Standard treatment is not available | 2 | [
"Standard",
"treatment",
"is",
"not",
"available"
] | [
1,
1,
0,
0,
0
] |
NCT02703272 | 16:66:chronic_disease | A diagnosis of post-transplant lymphoproliferative disease (PTLD) | 2 | [
"A",
"diagnosis",
"of",
"post-transplant",
"lymphoproliferative",
"disease",
"(",
"PTLD",
")"
] | [
0,
0,
0,
2,
2,
2,
2,
0,
0
] |
NCT02760498 | 16:50:chronic_disease,58:82:chronic_disease,88:105:chronic_disease,109:126:chronic_disease | Infection with human immunodeficiency virus (HIV) and/or chronic/active infection with hepatitis B virus or hepatitis C virus | 2 | [
"Infection",
"with",
"human",
"immunodeficiency",
"virus",
"(",
"HIV",
")",
"and/or",
"chronic/active",
"infection",
"with",
"hepatitis",
"B",
"virus",
"or",
"hepatitis",
"C",
"virus"
] | [
0,
0,
2,
2,
2,
2,
0,
0,
0,
2,
2,
0,
2,
2,
2,
0,
0,
0,
0
] |
NCT01925378 | ,92:109:treatment | have a satisfactory (readable, good quality) colposcopic evaluation at least 14 days after diagnostic biopsy | 2 | [
"have",
"a",
"satisfactory",
"(",
"readable",
",",
"good",
"quality",
")",
"colposcopic",
"evaluation",
"at",
"least",
"14",
"days",
"after",
"diagnostic",
"biopsy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT00914823 | 17:32:chronic_disease,34:43:chronic_disease,47:51:chronic_disease | no evidence for androgen excess (hirsutism or acne) | 2 | [
"no",
"evidence",
"for",
"androgen",
"excess",
"(",
"hirsutism",
"or",
"acne",
")"
] | [
0,
0,
0,
2,
2,
0,
2,
0,
2,
0
] |
NCT02806570 | 18:25:allergy_name,27:36:allergy_name,41:53:allergy_name | Known allergy to nitinol, polyester, or polyethylene | 2 | [
"Known",
"allergy",
"to",
"nitinol",
",",
"polyester",
",",
"or",
"polyethylene"
] | [
0,
0,
0,
4,
0,
4,
0,
0,
4
] |
NCT02555189 | 5:11:treatment,13:24:treatment,29:45:treatment,53:60:treatment,62:74:treatment,76:88:treatment,177:190:treatment,192:199:treatment,204:213:treatment | All herbal, alternative and food supplements (i.e., PC-Spes, Saw Palmetto, St John Wort, etc.). They must be discontinued prior to enrollment. Patients may continue on a daily Multi-Vitamin, calcium and Vitamin D | 2 | [
"All",
"herbal",
",",
"alternative",
"and",
"food",
"supplements",
"(",
"i.e.",
",",
"PC-Spes",
",",
"Saw",
"Palmetto",
",",
"St",
"John",
"Wort",
",",
"etc.",
")",
".",
"They",
"must",
"be",
"discontinued",
"prior",
"to",
"enrollment",
".",
"Patients",
... | [
0,
1,
0,
1,
0,
1,
1,
0,
0,
0,
1,
0,
1,
1,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0
] |
NCT02844738 | 16:41:chronic_disease, | Diagnosis of a transient ischemic attack in the 6 months prior to screening | 2 | [
"Diagnosis",
"of",
"a",
"transient",
"ischemic",
"attack",
"in",
"the",
"6",
"months",
"prior",
"to",
"screening"
] | [
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT03060096 | 1:26:cancer | non-melanoma skin cancers | 2 | [
"non-melanoma",
"skin",
"cancers"
] | [
3,
3,
3
] |
NCT01444209 | 36:74:treatment | Patients who are unable to undergo placement of a stereotactic head frame | 2 | [
"Patients",
"who",
"are",
"unable",
"to",
"undergo",
"placement",
"of",
"a",
"stereotactic",
"head",
"frame"
] | [
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
1
] |
NCT02848417 | 1:9:treatment | Steroids | 2 | [
"Steroids"
] | [
1
] |
NCT02931110 | 1:9:treatment | apixaban | 2 | [
"apixaban"
] | [
1
] |
NCT02048722 | 20:43:cancer,53:73:cancer,78:103:cancer | Exceptions include cervical cancer in-situ, treated basal cell carcinoma, or superficial bladder tumor | 2 | [
"Exceptions",
"include",
"cervical",
"cancer",
"in-situ",
",",
"treated",
"basal",
"cell",
"carcinoma",
",",
"or",
"superficial",
"bladder",
"tumor"
] | [
0,
0,
3,
3,
3,
0,
0,
3,
3,
3,
0,
0,
3,
3,
3
] |
NCT02037048 | 21:30:chronic_disease,36:70:chronic_disease | Patients with known infection with human immunodeficiency virus (HIV) will not be eligible | 2 | [
"Patients",
"with",
"known",
"infection",
"with",
"human",
"immunodeficiency",
"virus",
"(",
"HIV",
")",
"will",
"not",
"be",
"eligible"
] | [
0,
0,
0,
2,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT03006302 | 12:29:chronic_disease | History of Seratonin Syndome | 2 | [
"History",
"of",
"Seratonin",
"Syndome"
] | [
0,
0,
2,
2
] |
NCT02578641 | 1:31:chronic_disease | Severe intercurrent infections | 2 | [
"Severe",
"intercurrent",
"infections"
] | [
2,
2,
2
] |
NCT01978509 | 16:35:chronic_disease | Risk of severe cardiac arrhythmias | 2 | [
"Risk",
"of",
"severe",
"cardiac",
"arrhythmias"
] | [
0,
0,
0,
2,
2
] |
NCT02050113 | 1:22:chronic_disease | Anaphylactic reaction to contrast that cannot be adequately pre-medicated | 2 | [
"Anaphylactic",
"reaction",
"to",
"contrast",
"that",
"can",
"not",
"be",
"adequately",
"pre-medicated"
] | [
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00085982 | 1:9:chronic_disease,, | Diabetic symptoms with a random plasma glucose >= 200 mg/dL | 2 | [
"Diabetic",
"symptoms",
"with",
"a",
"random",
"plasma",
"glucose",
">",
"=",
"200",
"mg/dL"
] | [
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02860000 | ,114:125:treatment,,148:177:treatment,197:234:treatment,239:271:treatment | A non-nodal lesion is considered measurable if its longest diameter can be accurately measured as >= 2.0 cm with chest x-ray, or as >= 1.0 cm with computed tomography (CT) scan, CT component of a positron emission tomography (PET)/CT, or magnetic resonance imaging (MRI) | 2 | [
"A",
"non-nodal",
"lesion",
"is",
"considered",
"measurable",
"if",
"its",
"longest",
"diameter",
"can",
"be",
"accurately",
"measured",
"as",
">",
"=",
"2.0",
"cm",
"with",
"chest",
"x-ray",
",",
"or",
"as",
">",
"=",
"1.0",
"cm",
"with",
"computed",
"t... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
1,
1,
1,
1,
0,
0
] |
NCT02340650 | 37:57:chronic_disease | Patient with sufficient evidence of cognitive impairment that limits the subject's ability to understand the protocol | 2 | [
"Patient",
"with",
"sufficient",
"evidence",
"of",
"cognitive",
"impairment",
"that",
"limits",
"the",
"subject",
"'s",
"ability",
"to",
"understand",
"the",
"protocol"
] | [
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01877382 | ,29:43:treatment | within 3 weeks before study drug treatment | 2 | [
"within",
"3",
"weeks",
"before",
"study",
"drug",
"treatment"
] | [
0,
0,
0,
0,
0,
1,
1
] |
NCT03121352 | 35:56:treatment | Patients who have participated in MK-3475 Merck studies | 2 | [
"Patients",
"who",
"have",
"participated",
"in",
"MK-3475",
"Merck",
"studies"
] | [
0,
0,
0,
0,
0,
1,
1,
1
] |
NCT01989585 | ,,62:76:treatment,126:139:chronic_disease,140:148:chronic_disease | Abnormal cardiac valve morphology (>= grade 2) documented by echocardiogram (subjects with grade 1 abnormalities [i.e., mild regurgitation/stenosis] can be entered on study); subjects with moderate valvular thickening should not be entered on study | 2 | [
"Abnormal",
"cardiac",
"valve",
"morphology",
"(",
">",
"=",
"grade",
"2",
")",
"documented",
"by",
"echocardiogram",
"(",
"subjects",
"with",
"grade",
"1",
"abnormalities",
"[",
"i.e.",
",",
"mild",
"regurgitation/stenosis",
"]",
"can",
"be",
"entered",
"on",... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02435069 | 27:48:chronic_disease | children with preexisting electrolyte imbalance | 2 | [
"children",
"with",
"preexisting",
"electrolyte",
"imbalance"
] | [
0,
0,
0,
2,
2
] |
NCT02204098 | 1:22:treatment | Investigational agent | 2 | [
"Investigational",
"agent"
] | [
1,
1
] |
NCT02027948 | 37:49:treatment,71:88:treatment,,,,124:134:cancer,138:170:cancer | Patients who will receive induction chemotherapy followed by combined chemoradiotherapy at MSKCC for localized stage I-III esophageal or gastroesophageal junction cancer | 2 | [
"Patients",
"who",
"will",
"receive",
"induction",
"chemotherapy",
"followed",
"by",
"combined",
"chemoradiotherapy",
"at",
"MSKCC",
"for",
"localized",
"stage",
"I-III",
"esophageal",
"or",
"gastroesophageal",
"junction",
"cancer"
] | [
0,
0,
0,
0,
0,
1,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
3,
0,
3,
3,
3
] |
NCT02070549 | 24:38:chronic_disease | History or evidence of cardiovascular risk | 2 | [
"History",
"or",
"evidence",
"of",
"cardiovascular",
"risk"
] | [
0,
0,
0,
0,
2,
0
] |
NCT02166905 | 18:82:treatment, | Participation in any other clinical trial involving another investigational agent within 4 weeks prior to first dosing of study drug | 2 | [
"Participation",
"in",
"any",
"other",
"clinical",
"trial",
"involving",
"another",
"investigational",
"agent",
"within",
"4",
"weeks",
"prior",
"to",
"first",
"dosing",
"of",
"study",
"drug"
] | [
0,
0,
1,
1,
1,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02836574 | 21:35:chronic_disease,, | individuals who are morbidly obese (defined as BMI greater than 45 kg/m2), have excessive fat surrounding the kidney, or who are otherwise at excessive risk for serious complications | 2 | [
"individuals",
"who",
"are",
"morbidly",
"obese",
"(",
"defined",
"as",
"BMI",
"greater",
"than",
"45",
"kg/m2",
")",
",",
"have",
"excessive",
"fat",
"surrounding",
"the",
"kidney",
",",
"or",
"who",
"are",
"otherwise",
"at",
"excessive",
"risk",
"for",
"... | [
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02257424 | 37:71:treatment, | Patients must not receive any other investigational anticancer therapy during the period on study or the four weeks prior to entry | 2 | [
"Patients",
"must",
"not",
"receive",
"any",
"other",
"investigational",
"anticancer",
"therapy",
"during",
"the",
"period",
"on",
"study",
"or",
"the",
"four",
"weeks",
"prior",
"to",
"entry"
] | [
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01504373 | 1:33:treatment | Uncuffed endotracheal tube (ETT) | 2 | [
"Uncuffed",
"endotracheal",
"tube",
"(",
"ETT",
")"
] | [
1,
1,
1,
1,
0,
0
] |
NCT02080221 | 10:29:cancer, | No prior invasive malignancy within the prior two years | 2 | [
"No",
"prior",
"invasive",
"malignancy",
"within",
"the",
"prior",
"two",
"years"
] | [
0,
0,
3,
3,
0,
0,
0,
0,
0
] |
NCT01950234 | 1:22:treatment,11:22:treatment,44:59:treatment,61:70:treatment,72:83:treatment,85:95:treatment,99:116:treatment | Stimulant medications for fatigue (such as methylphenidate, modafinil, armodafinil, amantadine or dextroamphetamine) will be permitted, but subjects will be asked to not take these medications on study visit days until all study procedures/assessments are completed | 2 | [
"Stimulant",
"medications",
"for",
"fatigue",
"(",
"such",
"as",
"methylphenidate",
",",
"modafinil",
",",
"armodafinil",
",",
"amantadine",
"or",
"dextroamphetamine",
")",
"will",
"be",
"permitted",
",",
"but",
"subjects",
"will",
"be",
"asked",
"to",
"not",
... | [
1,
1,
0,
0,
0,
0,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02593123 | 9:44:treatment | revious myeloablative autologous transplant is permitted but not required | 2 | [
"revious",
"myeloablative",
"autologous",
"transplant",
"is",
"permitted",
"but",
"not",
"required"
] | [
0,
1,
1,
1,
0,
0,
0,
0,
0
] |
NCT03149783 | 7:30:treatment | other sodium channel blockers | 2 | [
"other",
"sodium",
"channel",
"blockers"
] | [
0,
1,
1,
1
] |
NCT02508038 | 21:41:chronic_disease,55:61:cancer,69:78:treatment, | Significant serious intercurrent illness unrelated to cancer or its treatment not covered by other exclusion criteria expected to significantly increase the risk of HSCT | 2 | [
"Significant",
"serious",
"intercurrent",
"illness",
"unrelated",
"to",
"cancer",
"or",
"its",
"treatment",
"not",
"covered",
"by",
"other",
"exclusion",
"criteria",
"expected",
"to",
"significantly",
"increase",
"the",
"risk",
"of",
"HSCT"
] | [
0,
0,
2,
2,
0,
0,
3,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01419561 | 1:6:chronic_disease,8:15:chronic_disease,17:39:chronic_disease,44:62:chronic_disease | Cough, dyspnea, airway hyperreactivity, or nasal inflammation | 2 | [
"Cough",
",",
"dyspnea",
",",
"airway",
"hyperreactivity",
",",
"or",
"nasal",
"inflammation"
] | [
2,
0,
2,
0,
2,
2,
0,
0,
2,
2
] |
NCT02273362 | 19:43:treatment | An indication for surgical liver resection | 2 | [
"An",
"indication",
"for",
"surgical",
"liver",
"resection"
] | [
0,
0,
0,
1,
1,
1
] |
NCT02177838 | 32:48:treatment,59:76:cancer,88:100:treatment,102:119:treatment,124:131:treatment | Patients may not have received previous therapy for their head and neck SCC, including chemotherapy, radiation therapy, or surgery beyond biopsy | 2 | [
"Patients",
"may",
"not",
"have",
"received",
"previous",
"therapy",
"for",
"their",
"head",
"and",
"neck",
"SCC",
",",
"including",
"chemotherapy",
",",
"radiation",
"therapy",
",",
"or",
"surgery",
"beyond",
"biopsy"
] | [
0,
0,
0,
0,
0,
1,
1,
0,
0,
3,
3,
3,
3,
0,
0,
1,
0,
1,
1,
0,
0,
1,
0,
0
] |
NCT03010852 | 1:15:treatment, | Oxygen therapy within the previous 30 days | 2 | [
"Oxygen",
"therapy",
"within",
"the",
"previous",
"30",
"days"
] | [
1,
1,
0,
0,
0,
0,
0
] |
NCT01953263 | 15:31:chronic_disease | Patients with vaginal prolapse beyond introitus | 2 | [
"Patients",
"with",
"vaginal",
"prolapse",
"beyond",
"introitus"
] | [
0,
0,
2,
2,
0,
0
] |
NCT02442102 | 33:53:cancer | Head and/or neck disease (e.g., oropharyngeal cancer) | 2 | [
"Head",
"and/or",
"neck",
"disease",
"(",
"e.g.",
",",
"oropharyngeal",
"cancer",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
3,
3,
0
] |
NCT01037790 | ,,,158:174:treatment | Sexually active subjects (male and female) must use accepted methods of contraception during the course of the study and for 3 months after the last dose of protocol drug(s) | 2 | [
"Sexually",
"active",
"subjects",
"(",
"male",
"and",
"female",
")",
"must",
"use",
"accepted",
"methods",
"of",
"contraception",
"during",
"the",
"course",
"of",
"the",
"study",
"and",
"for",
"3",
"months",
"after",
"the",
"last",
"dose",
"of",
"protocol",
... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0
] |
NCT02343549 | 26:29:cancer | Pathological evidence of GBM using WHO classification criteria | 2 | [
"Pathological",
"evidence",
"of",
"GBM",
"using",
"WHO",
"classification",
"criteria"
] | [
0,
0,
0,
3,
0,
0,
0,
0
] |
NCT02574728 | 19:32:cancer | participants with pineal tumors and elevations of serum or cerebrospinal fluid (CSF) alpha-fetoprotein (AFP) or beta-human chorionic gonadotropin (beta-HCG) | 2 | [
"participants",
"with",
"pineal",
"tumors",
"and",
"elevations",
"of",
"serum",
"or",
"cerebrospinal",
"fluid",
"(",
"CSF",
")",
"alpha-fetoprotein",
"(",
"AFP",
")",
"or",
"beta-human",
"chorionic",
"gonadotropin",
"(",
"beta-HCG",
")"
] | [
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01893307 | 10:28:treatment | Previous surgical resection | 2 | [
"Previous",
"surgical",
"resection"
] | [
0,
1,
1
] |
NCT01280669 | 1:20:treatment, | Intraocular surgery within 90 days prior to Day 0 in the study eye | 2 | [
"Intraocular",
"surgery",
"within",
"90",
"days",
"prior",
"to",
"Day",
"0",
"in",
"the",
"study",
"eye"
] | [
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02513797 | 1:33:chronic_disease | Left atrial appendage morphology: Superior-posterior oriented left atrial appendage (i.e. superior C shape), that has Left atrial appendage distal apex extending posterior to the ostium of the appendage | 2 | [
"Left",
"atrial",
"appendage",
"morphology",
":",
"Superior-posterior",
"oriented",
"left",
"atrial",
"appendage",
"(",
"i.e",
".",
"superior",
"C",
"shape",
")",
",",
"that",
"has",
"Left",
"atrial",
"appendage",
"distal",
"apex",
"extending",
"posterior",
"to"... | [
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02956486 | 12:48:chronic_disease, | History of transient ischemic attacks or stroke within 12 months of Screening | 2 | [
"History",
"of",
"transient",
"ischemic",
"attacks",
"or",
"stroke",
"within",
"12",
"months",
"of",
"Screening"
] | [
0,
0,
2,
2,
2,
2,
2,
0,
0,
0,
0,
0
] |
NCT01280994 | 1:20:chronic_disease,26:35:chronic_disease,39:53:chronic_disease,,72:75:treatment | Respiratory illness of a bacterial or viral etiology within 30 days of MRI | 2 | [
"Respiratory",
"illness",
"of",
"a",
"bacterial",
"or",
"viral",
"etiology",
"within",
"30",
"days",
"of",
"MRI"
] | [
2,
2,
0,
0,
2,
0,
2,
2,
0,
0,
0,
0,
1
] |
NCT02008656 | 10:32:treatment,44:56:treatment,58:67:treatment,69:87:treatment,78:87:treatment,89:105:treatment,107:120:treatment,122:134:treatment,136:151:treatment,153:176:treatment,178:211:treatment,213:224:treatment,226:261:treatment,271:289:treatment | No other experimental therapies (including chemotherapy, radiation, hormonal treatment, antibody therapy, immunotherapy, gene therapy, vaccine therapy, angiogenesis inhibitors, matrix metalloprotease inhibitors, thalidomide, anti-VEGF/Flk-1 monoclonal antibody or other experimental drugs) of any kind are permitted whil... | 2 | [
"No",
"other",
"experimental",
"therapies",
"(",
"including",
"chemotherapy",
",",
"radiation",
",",
"hormonal",
"treatment",
",",
"antibody",
"therapy",
",",
"immunotherapy",
",",
"gene",
"therapy",
",",
"vaccine",
"therapy",
",",
"angiogenesis",
"inhibitors",
",... | [
0,
0,
1,
1,
0,
0,
1,
0,
1,
0,
1,
1,
0,
1,
1,
0,
1,
0,
1,
1,
0,
1,
1,
0,
1,
1,
0,
1,
1,
1,
0,
1,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00914823 | 42:57:treatment | able to undergo appropriate washout from hormone therapy | 2 | [
"able",
"to",
"undergo",
"appropriate",
"washout",
"from",
"hormone",
"therapy"
] | [
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT01967238 | 12:28:chronic_disease | History of seizure disorder for Flumist group participants only | 2 | [
"History",
"of",
"seizure",
"disorder",
"for",
"Flumist",
"group",
"participants",
"only"
] | [
0,
0,
2,
2,
0,
0,
0,
0,
0
] |
NCT02452268 | 14:32:chronic_disease | Evaluable or measurable disease, defined as by Response Evaluation Criteria in Solid Tumors (RECIST) | 2 | [
"Evaluable",
"or",
"measurable",
"disease",
",",
"defined",
"as",
"by",
"Response",
"Evaluation",
"Criteria",
"in",
"Solid",
"Tumors",
"(",
"RECIST",
")"
] | [
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01042522 | 1:31:chronic_disease,, | Neuropathy (sensory and motor) less than or equal to CTCAE grade 1 | 2 | [
"Neuropathy",
"(",
"sensory",
"and",
"motor",
")",
"less",
"than",
"or",
"equal",
"to",
"CTCAE",
"grade",
"1"
] | [
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01538966 | 21:37:chronic_disease | The patient has any mental condition rendering the patient unable to understand the nature, scope, and possible consequences of the study, and/or evidence of an uncooperative attitude | 2 | [
"The",
"patient",
"has",
"any",
"mental",
"condition",
"rendering",
"the",
"patient",
"unable",
"to",
"understand",
"the",
"nature",
",",
"scope",
",",
"and",
"possible",
"consequences",
"of",
"the",
"study",
",",
"and/or",
"evidence",
"of",
"an",
"uncooperati... | [
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02176161 | 35:53:chronic_disease,83:104:chronic_disease,106:129:treatment,131:146:chronic_disease,148:167:chronic_disease,188:212:chronic_disease,217:241:chronic_disease, | any unstable, serious co-existing medical conditions including but not limited to myocardial infarction, coronary bypass surgery, unstable angina, cardiac arrhythmias, clinically evident congestive heart failure, or cerebrovascular accident within 6 months prior to screening | 2 | [
"any",
"unstable",
",",
"serious",
"co-existing",
"medical",
"conditions",
"including",
"but",
"not",
"limited",
"to",
"myocardial",
"infarction",
",",
"coronary",
"bypass",
"surgery",
",",
"unstable",
"angina",
",",
"cardiac",
"arrhythmias",
",",
"clinically",
"e... | [
0,
2,
2,
0,
0,
2,
2,
0,
0,
0,
0,
0,
2,
2,
0,
1,
1,
1,
0,
0,
0,
0,
2,
2,
0,
0,
0,
2,
2,
2,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT03065972 | 26:47:chronic_disease | Diagnosed with End-stage Renal Disease stage 4 | 2 | [
"Diagnosed",
"with",
"End-stage",
"Renal",
"Disease",
"stage",
"4"
] | [
0,
0,
0,
2,
2,
2,
2
] |
NCT02419495 | 28:43:cancer,37:43:cancer,,97:102:cancer,106:141:cancer | Diagnosis or recurrence of invasive cancer other than the present cancer within 3 years (except basal or squamous cell carcinoma of the skin that has been definitively treated) | 2 | [
"Diagnosis",
"or",
"recurrence",
"of",
"invasive",
"cancer",
"other",
"than",
"the",
"present",
"cancer",
"within",
"3",
"years",
"(",
"except",
"basal",
"or",
"squamous",
"cell",
"carcinoma",
"of",
"the",
"skin",
"that",
"has",
"been",
"definitively",
"treate... | [
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
3,
3,
3,
3,
3,
3,
0,
0,
0,
0,
0,
0
] |
NCT02451553 | 1:31:chronic_disease,87:102:treatment,124:153:treatment,155:180:treatment,210:230:chronic_disease,234:250:chronic_disease | Gastrointestinal tract disease or any other reasons resulting in an inability to take oral medication or a requirement for intravenous (IV) alimentation, prior surgical procedures affecting absorption, active peptic ulcer disease or chronic diarrhea | 2 | [
"Gastrointestinal",
"tract",
"disease",
"or",
"any",
"other",
"reasons",
"resulting",
"in",
"an",
"inability",
"to",
"take",
"oral",
"medication",
"or",
"a",
"requirement",
"for",
"intravenous",
"(",
"IV",
")",
"alimentation",
",",
"prior",
"surgical",
"procedur... | [
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
2,
2,
2,
0,
2,
2
] |
NCT02734602 | 1:27:chronic_disease | neurodegenerative disorder | 2 | [
"neurodegenerative",
"disorder"
] | [
2,
2
] |
NCT03033498 | 29:42:chronic_disease | has a diagnosis of definite idiopathic PD | 2 | [
"has",
"a",
"diagnosis",
"of",
"definite",
"idiopathic",
"PD"
] | [
0,
0,
0,
0,
0,
2,
2
] |
NCT03112590 | 31:53:chronic_disease | Known current or a history of hepatitis B or C virus, including chronic and dormant states, unless disease has been treated and confirmed cleared | 2 | [
"Known",
"current",
"or",
"a",
"history",
"of",
"hepatitis",
"B",
"or",
"C",
"virus",
",",
"including",
"chronic",
"and",
"dormant",
"states",
",",
"unless",
"disease",
"has",
"been",
"treated",
"and",
"confirmed",
"cleared"
] | [
0,
0,
0,
0,
0,
0,
2,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01954173 | 1:38:treatment | Prior radiation therapy to the pelvis | 2 | [
"Prior",
"radiation",
"therapy",
"to",
"the",
"pelvis"
] | [
1,
1,
1,
1,
1,
1
] |
NCT02669173 | 1:24:cancer,32:47:chronic_disease,49:70:chronic_disease,72:78:chronic_disease, | Arterial ischemic event (e.g., unstable angina, myocardial infarction, stroke) within 6 months of study entry | 2 | [
"Arterial",
"ischemic",
"event",
"(",
"e.g.",
",",
"unstable",
"angina",
",",
"myocardial",
"infarction",
",",
"stroke",
")",
"within",
"6",
"months",
"of",
"study",
"entry"
] | [
3,
3,
3,
0,
0,
0,
2,
2,
0,
2,
2,
0,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT03140527 | 1:7:cancer,,43:66:cancer,72:88:treatment,,134:158:cancer | cancer within the past 5 years (excluding cervical cancer in situ with curative therapy for at least one year prior to screening and non-melanoma skin cancer) | 2 | [
"cancer",
"within",
"the",
"past",
"5",
"years",
"(",
"excluding",
"cervical",
"cancer",
"in",
"situ",
"with",
"curative",
"therapy",
"for",
"at",
"least",
"one",
"year",
"prior",
"to",
"screening",
"and",
"non-melanoma",
"skin",
"cancer",
")"
] | [
3,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
3,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
0
] |
NCT02503358 | 40:56:chronic_disease,100:116:chronic_disease,125:143:chronic_disease,147:163:treatment,201:212:chronic_disease,214:225:chronic_disease,230:263:chronic_disease | Any evidence of severe or uncontrolled systemic disease, including, but not limited to, ongoing or active infection, active bleeding diatheses or renal transplant, including any patient known to have hepatitis B, hepatitis C, or human immunodeficiency virus (HIV | 2 | [
"Any",
"evidence",
"of",
"severe",
"or",
"uncontrolled",
"systemic",
"disease",
",",
"including",
",",
"but",
"not",
"limited",
"to",
",",
"ongoing",
"or",
"active",
"infection",
",",
"active",
"bleeding",
"diatheses",
"or",
"renal",
"transplant",
",",
"includ... | [
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
2,
2,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
2,
2,
2,
2,
0
] |
NCT03037385 | 58:78:cancer | have a pathologically documented, definitively diagnosed advanced solid tumor with an oncogenic RET mutation previously treated with SOC appropriate for the tumor type and not eligible for any of the other groups | 2 | [
"have",
"a",
"pathologically",
"documented",
",",
"definitively",
"diagnosed",
"advanced",
"solid",
"tumor",
"with",
"an",
"oncogenic",
"RET",
"mutation",
"previously",
"treated",
"with",
"SOC",
"appropriate",
"for",
"the",
"tumor",
"type",
"and",
"not",
"eligible... | [
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02912572 | 1:27:chronic_disease | Grade 2 sensory neuropathy | 2 | [
"Grade",
"2",
"sensory",
"neuropathy"
] | [
2,
2,
2,
2
] |
NCT02446457 | 11:35:treatment,57:82:treatment,,124:139:treatment | receiving systemic steroid therapy or any other form of immunosuppressive therapy within 7 days prior to the first dose of trial treatment | 2 | [
"receiving",
"systemic",
"steroid",
"therapy",
"or",
"any",
"other",
"form",
"of",
"immunosuppressive",
"therapy",
"within",
"7",
"days",
"prior",
"to",
"the",
"first",
"dose",
"of",
"trial",
"treatment"
] | [
0,
1,
1,
1,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02329652 | 1:29:chronic_disease | severe autonomic dysreflexia | 2 | [
"severe",
"autonomic",
"dysreflexia"
] | [
2,
2,
2
] |
NCT02566304 | 1:3:chronic_disease,7:11:chronic_disease,43:53:treatment,66:75:treatment | RA or RARS or isolated 5q- can proceed to transplant without any treatment | 2 | [
"RA",
"or",
"RARS",
"or",
"isolated",
"5q-",
"can",
"proceed",
"to",
"transplant",
"without",
"any",
"treatment"
] | [
2,
0,
2,
0,
0,
0,
0,
0,
0,
1,
0,
0,
1
] |
NCT02122185 | ,,,,79:107:cancer | carcinoembryonic antigen (CEA) ratio > 25 OR CA125 =< 250 with no evidence of gastrointestinal (GI) cancer | 2 | [
"carcinoembryonic",
"antigen",
"(",
"CEA",
")",
"ratio",
">",
"25",
"OR",
"CA125",
"=",
"<",
"250",
"with",
"no",
"evidence",
"of",
"gastrointestinal",
"(",
"GI",
")",
"cancer"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
0,
0
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.